medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2018, Number 4

<< Back Next >>

Acta Med 2018; 16 (4)

Systemic lupus erythematosus in pregnancy

Stuht LD, Santoyo HS, Lara BI

Language: Spanish
References: 49
Page: 331-338
PDF size: 147.37 Kb.


ABSTRACT

Systemic lupus erythematosus (LES), is a chronic, inflammatory and multisystemic disease characterized by an aberrant autoimmune response to autoantigens that attacks any organ or tissue, affecting primarily women in reproductive age. In the United States of America, LES affects nearly 300,000 people, primarily women with a ratio female: male of 10:1. The aim of this article is to resume the primary risks of pregnancy associated to LES, as well as the general recommendations for preconceptional period and treatment during pregnancy and lactation.


REFERENCES

  1. Golder V, Hoi A. Systemic lupus erythematosus: an update. Med J Aust. 2017; 206 (5): 215-220.

  2. Paglia G, Leone M, Lepri G. One year in review 2017: systemic lupus erythematosus. Clin Exp Rheumatol. 2017; 35: 551-561.

  3. Vu Lam NC, Ghetu M, Bieniek M. Systemic lupus erythematosus: primary care approach to diagnosis and management. Am Fam Physician. 2016; 94 (4): 284-294.

  4. Tsokos G. Systemic lupus erythematosus. NEJM. 2011; 365: 2110-2121.

  5. Nucamendi C. Boletín epidemiológico (Sistema Nacional de Vigilancia Epidemiológico, Sistema Único de información): ¿Qué es el lupus eritematoso? México, 2013. Recuperado de: https://www.gob.mx/cms/uploads/attachment/file/13761/2013_30.pdf.

  6. Centro Estatal de Vigilancia Epidemiológica y Control de Enfermedades (2017). Lo que debes de saber del lupus. Estado de México. Recuperado de: http://salud.edomex.gob.mx/cevece/documentos/difusion/tripticos/2017/Semana%2019.pdf.

  7. Doria A, Laccarino L, Arienti S et al. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol. 2006; 22: 234-241.

  8. Narcés-Torices MA, Hernández-Pacheco JA, Estrada-Altamirano A y cols. Lupus eritematoso sistémico activo durante el embarazo, curso clínico y pronóstico en una Unidad de Cuidados Intensivos. Perinatol Reprod Hum. 2012; 26 (2): 96-105.

  9. Molad Y, Brokowski T, Monselise A et al. Maternal and fetal outcome of lupus pregnancy: a prospective study of 29 pregnancies. Lupus. 2005; 14: 145-151.

  10. Kroese S, Abheiden C, Blomjoues B et al. Maternal and perinatal outcome in women with systemic lupus erythematosus: a retrospective bicenter cohort study. J Immunol. 2013; 2017: 1-9.

  11. Bundhun PK, Soogund MZ, Huang F. Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: a meta-analysis of studies published between years 2001-2016. J Autoimmun. 2017; 79: 17-27.

  12. Saavedra MA, Miranda-Hernández D, Sánchez A et al. Pregnancy outcomes in women with childhood-onset
and adult-onset systemic lupus erythematosus: a comparative study. Rheumatol Int. 2016; 36: 1431-1437.

  13. Zhan Z, Yang Y, Zhan Y et al. Fetal outcomes and associated factors of adverse outcomes of pregnancy in southern Chinese women with systemic lupus erythematosus. PLoS ONE. 2017; 12 (4): e0176457. https://doi.org/10.1371/journal.pone.0176457.

  14. Phansenee S, Sekararithi R, Jatavan P et al. Pregnancy outcomes among women with systemic lupus erythematosus: a retrospective cohort study from Thailand. Lupus. 2018; 27: 158-164.

  15. Farfan-Labonne B, Luis-Vásquez I, Ávila-Carrasco A y cols. Resultados perinatales en mujeres mexicanas con lupus eritematoso sistémico. Perinatol Reprod Hum. 2017; 31 (1): 3-9.

  16. Doria A, Tincani A, Lockshin M. Challenges of lupus pregnancies. Rheumatology. 2008; 47: iii9-iii12.

  17. Andreoli L, Bertsias GK, Agmon-Levin N et al. EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 2017; 76 (3): 476-485. doi: 10.1136/annrheumdis-2016-209770.

  18. Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: ten questions and some answers. Lupus. 2008; 17 (5): 416-420.

  19. Marder W, Littlejohn E, Somers E. Pregnancy and autoimmune connective tissue diseases. Best Pract Res Clin Rheumatol. 2016; 30 (1): 63-80.

  20. Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: integrating clues from the bench and bedside. Eur J Clin Invest. 2010; 41 (6): 672-678.

  21. Saavedra MA, Barrera A, Cabral A y cols. Guías de práctica clínica para la atención del embarazo en mujeres con enfermedades reumáticas autoinmunes del Colegio Mexicano de Reumatología. Parte 1. Reumatol Clin. 2015; 11 (5): 295-304.

  22. Oktem O, Yagmur H, Bengisu H, Urman B. Reproductive aspects of systemic lupus erythematosus. J Reprod Immunol. 2016; 117: 57-65.

  23. Khamashta MA. Systemic lupus erythematosus and pregnancy. Best Pract Res Clin Rheumatol. 2006; 20: 685-694.

  24. Lockshin MD, Sammaritano LR. Lupus pregnancy. Autoimmunity. 2003; 36 (1): 33-40.

  25. Andreoli L, Crisafulli F, Tincani A. Pregnancy and reproductive aspects of systemic lupus erythematous. Curr Opin Rheumatol. 2017; 29: 473-479.

  26. Erkan D, Sammaritano L. New insights into pregnancy-related complications in systemic lupus erythematosus. Curr Rheumatol Rep. 2003; 5: 357-363.

  27. Izmirly PM, Rivera TL, Buyon JP. Neonatal lupus syndromes. Rheum Dis Clin North Am. 2007; 33: 267-285.

  28. Al-Janadi M, al-Balla S, al-Dalaan A, Raziuddin S. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis and other rheumatic disease. J Clin Immunol. 1993; 13: 58-67.

  29. Diehl S, Rincon M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol. 2002; 39: 531-536.

  30. Petri M. Sex hormones and systemic lupus erythematosus. Lupus. 2008; 17: 412-415.

  31. González L, Restrepo M. Lupus eritematoso sistémico y embarazo. Rev Col Reumatol. 2011; 18 (3): 175-186.

  32. Kattah A, Garovic V. Pregnancy and lupus nephritis. Sem Nephrol. 2015; 35 (5): 487-499.

  33. Lightstone L, Hladunewich M. Lupus nephritis and pregnancy: concerns and management. Sem Nephrol. 2017; 37 (49): 347-353.

  34. Jara L, Medina G, Cruz-Dominguez P et al. Risk factors of systemic lupus erythematosus flares during pregnancy. Immunol Res. 2014; 60 (2-3): 184-192.

  35. Moroni G, Ponticelli C. Pregnancy in women with systemic lupus erythematosus (SLE). Eur J Intern Med. 2016; 32: 7-12.

  36. Barbhaiya M, Bermas B. Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy. Clin Immunol. 2013; 149 (2): 225-235.

  37. Clowse ME, Magder L, Witter F et al. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006; 54: 3640-3647.

  38. Leroux M, Desveaux C, Parcevaux M et al. Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive 
cohort study. Lupus. 2015; 24: 1384-1391.

  39. Ugarte A, Villar I, Ruiz-Irastorza G. Manejo del embarazo en pacientes con lupus eritematoso sistémico. Rev Clin Esp. 2012; 212 (10): 491-498.

  40. Baer AN, Witter FR, Petri M. Lupus and pregnancy. Obstet Gynecol Surv. 2011; 66: 639-653.

  41. Sammaritano L. Management of systemic lupus erythematosus during pregnancy. Annu Rev Med. 2017; 68: 271-285.

  42. Petri M. The Hopkins lupus pregnancy center: ten keys issues in management. Rheum Dis Clin North Am. 2007; 33 (2): 227-235.

  43. Lateef A, Petri M. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol. 2013; 27 (3): 435-447.

  44. Ostensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Research & Therapy. 2006; 8 (3): 209.

  45. Ruiz-Irastorza G, Lima F, Alves J, Khamashta MA, Simpson J, Hughes GR et al. Increased rate of lupus flare during pregnancy and the puerperium: A prospective study of 78 pregnancies. Br J Rheumatol. 1996; 35: 133-138.

  46. Webster P, Wardle A, Bramham K et al. Tacrolimus is an effective treatment for lupus nephritis in pregnancy. Lupus. 2014; 23: 1192-1196.

  47. Perricone R, de Carolis C, Kröegler B et al. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. Rheumatol. 2008; 47: 646-651.

  48. World Health Organization. Breastfeeding health topic. [Accessed on 12 March 2018] Available at: http://www.who.int/topics/breastfeeding/es.

  49. Acevedo M, Petrini J, Micelli M et al. Breastfeeding initiation, duration, and reasons for weaning in patients with systemic lupus erythematosus. Rheumatol Int. 2017; 37: 1183-1186.




2020     |     www.medigraphic.com